These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22342104)

  • 1. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
    Fulda S
    Cancer Treat Rev; 2012 Oct; 38(6):760-6. PubMed ID: 22342104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IAP proteins in combination with radiotherapy.
    Fulda S
    Radiat Oncol; 2015 Apr; 10():105. PubMed ID: 25927408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.
    Fulda S
    Clin Cancer Res; 2014 Jan; 20(2):289-95. PubMed ID: 24270683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
    de Almagro MC; Vucic D
    Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitor of apoptosis proteins as therapeutic targets in cancer.
    Vucic D; Fairbrother WJ
    Clin Cancer Res; 2007 Oct; 13(20):5995-6000. PubMed ID: 17947460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
    Varfolomeev E; Vucic D
    Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.
    Fulda S
    Leukemia; 2014 Jul; 28(7):1414-22. PubMed ID: 24487414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule pan-IAP antagonists: a patent review.
    Flygare JA; Fairbrother WJ
    Expert Opin Ther Pat; 2010 Feb; 20(2):251-67. PubMed ID: 20100005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappaB independent mechanisms.
    Baust H; Schoke A; Brey A; Gern U; Los M; Schmid RM; Röttinger EM; Seufferlein T
    Oncogene; 2003 Nov; 22(54):8786-96. PubMed ID: 14647473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IAP-targeted therapies for cancer.
    LaCasse EC; Mahoney DJ; Cheung HH; Plenchette S; Baird S; Korneluk RG
    Oncogene; 2008 Oct; 27(48):6252-75. PubMed ID: 18931692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitors of apoptosis: there is more to life than Bcl2.
    Liston P; Fong WG; Korneluk RG
    Oncogene; 2003 Nov; 22(53):8568-80. PubMed ID: 14634619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.